跳至主要内容
临床试验/NCT02037854
NCT02037854Unknown不适用

PEP-1324: Glycemic Response Testing

PepsiCo Global R&D2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2014年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
12
试验地点
2
主要终点
Incremental area under the blood glucose response cruve

研究概览

简要总结

The purpose of this study is to assess whether food ingredient(s) affect glycemic and insulinemic responses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is 18-75 years of age
  • Subject is male or non-pregnant females, 18-75 years of age, inclusive
  • Subject has a body mass index (BMI) ≥ 20.0 and < 35 kg/m² at screening (visit 1).
  • Subject has to be non-smoker.
  • Subject is willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
  • Subject is willing to maintain current dietary supplement use throughout the trial. On test days, subject agrees not to take any dietary supplements until dismissal from the GI labs. Failure to comply will result in a rescheduled test visit.
  • Subject has normal fasting serum glucose (<7.0mmol/L capillary corresponding to whole blood glucose <6.3mmol/L).
  • Subject is willing to abstain from alcohol consumption and avoid vigorous physical activity for 24 h prior to all test visits.
  • Subject has no health conditions that would prevent him from fulfilling the study requirements as judged by the Investigator on the basis of medical history.
  • Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study investigator.

排除标准

  • 未提供

研究组 & 干预措施

Placebo

Placebo Comparator

A nutrient formulation without the active ingredient

干预措施: Nutrient formulation (Other)

Nutrient formulation

Experimental

Nutrient formulations with variable amounts of active ingredients.

干预措施: Nutrient formulation (Other)

结局指标

主要结局

Incremental area under the blood glucose response cruve

时间窗: 0-2 hours

次要结局

  • peak insulin(0-2 hours)
  • peak blood glucose(0-2 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验